Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
The Clinical Journal of Pain|January 8, 2014
The impact of buprenorphine transdermal delivery system on activities of daily living among patients with chronic low back pain: an application of the international classification of functioning, disability and healthKate Miller, Aaron Yarlas, Warren Wen, et al.
The Journal of Investigative Dermatology|May 23, 2025
Systemic Inflammatory Markers Correlate with Chronic Kidney Disease-Associated Pruritus and Response to TreatmentRobert H Spencer, Stephen A Kilfeather, Elaine Lee, et al.
Postgraduate Medicine|December 20, 2014
Buprenorphine transdermal system compared with placebo reduces interference in functioning for chronic low back painAaron Yarlas, Kate Miller, Warren Wen, et al.
The Journal of Pain|December 4, 2012
A randomized, placebo-controlled study of the impact of the 7-day buprenorphine transdermal system on health-related quality of life in opioid-naïve patients with moderate-to-severe chronic low back painAaron Yarlas, Kate Miller, Warren Wen, et al.
American Journal of Nephrology|January 22, 2024
Difelikefalin in Black/African American Hemodialysis Patients with Moderate-to-Severe Pruritus: Post hoc Analysis of KALM-1 and KALM-2Steven Fishbane, Deborah J Clegg, Edgar V Lerma, et al.
Pain Practice : the Official Journal of World Institute of Pain|April 14, 2015
A Subgroup Analysis Found no Diminished Response to Buprenorphine Transdermal System Treatment for Chronic Low Back Pain Patients Classified with DepressionAaron Yarlas, Kate Miller, Warren Wen, et al.
Kidney Medicine|October 3, 2022
Safety and Effectiveness of Difelikefalin in Patients With Moderate-to-Severe Pruritus Undergoing Hemodialysis: An Open-Label, Multicenter StudyDaniel E Weiner, Marc G Vervloet, Sebastian Walpen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 15, 2023
Difelikefalin improves itch-related sleep disruption in patients undergoing haemodialysisDaniel E Weiner, Thilo Schaufler, Kieran McCafferty, et al.
Kidney Medicine|August 26, 2022
Efficacy of Difelikefalin for the Treatment of Moderate to Severe Pruritus in Hemodialysis Patients: Pooled Analysis of KALM-1 and KALM-2 Phase 3 StudiesJoel Topf, Thomas Wooldridge, Kieran McCafferty, et al.
Kidney Medicine|January 16, 2024
CKD-Associated Pruritus and Clinical Outcomes in Nondialysis CKDJennifer S Scherer, Charlotte Tu, Ronald L Pisoni, et al.
Pageof 4